Posts Tagged: Teva Pharmaceuticals USA
Allergan’s RESTASIS® patents declared invalid by Eastern District of Texas
Judge William C. Bryson of the United States Federal District Court for the Eastern District of Texas found that Allergan's RESTASIS® patents were infringed by Teva Pharmaceuticals …
Obviousness-Type Double Patenting Considerations
Obviousness-type double patenting (“ODP”) is a judicially created doctrine aimed at preventing patent owners from extending patent protection beyond the statutorily afforded term. Prior to the Uruguay …
CAFC Interprets AIA On-Sale Bar: Invention details need not be public for sale to be invalidating
Earlier today the United States Court of Appeals for the Federal Circuit issued a major decision interpreting provisions of the America Invents Act (AIA), specifically the AIA …
